title: 12-Lipoxygenase products modulate calcium signals in vascular smooth muscle cells.
abstract: Previous studies have shown that inhibition of the lipoxygenase pathway of arachidonic acid metabolism can prevent the development of elevated blood pressure in renin-dependent models of hypertension. Agents that inhibit the lipoxygenase pathway such as phenidone and the flavonoid baicalein can selectively attenuate contractile responses to angiotensin II in vivo as well as in isolated vascular tissue. In the present study, the effects of lipoxygenase inhibitors on pressor-induced changes in cytosolic calcium were examined in cultured rat vascular smooth muscle cells using the fluorescent dye fura-2. Two structurally unrelated lipoxygenase inhibitors, baicalein and 5,8,11-eicosatriynoic acid, attenuated angiotensin II-stimulated increases in cytosolic calcium in both normal and calcium-poor buffer. The addition of 5-, 12-, or 15(S)-hydroxyeicosatetraenoic acid alone to the cells had no acute effect on intracellular calcium concentration. However, the addition of 12(S)-hydroxyeicosatetraenoic acid but not 5- or 15(S)-hydroxyeicosatetraenoic acid restored the initial calcium response to angiotensin II in vascular smooth muscle cells pretreated with both inhibitors; 5,8,11-eicosatriynoic acid also reduced [Arg8]-vasopressin and endothelin-stimulated increases in intracellular calcium. The attenuation of vasopressor-induced calcium transients by agents that inhibit lipoxygenase may explain their observed hypotensive effects in vivo. Moreover, lipoxygenase products, in particular 12(S)-hydroxyeicosatetraenoic acid, may act as mediators for the intracellular actions of angiotensin II and possibly other pressor hormones in vascular tissue by regulation of intracellular calcium metabolism.
authors.affiliation: Veterans Administration Medical Center, Sepulveda, CA 91343.
authors.forename: F
authors.initials: F
authors.lastname: Saito
authors.forename: M T
authors.initials: MT
authors.lastname: Hori
authors.forename: Y
authors.initials: Y
authors.lastname: Ideguchi
authors.forename: M
authors.initials: M
authors.lastname: Berger
authors.forename: M
authors.initials: M
authors.lastname: Golub
authors.forename: N
authors.initials: N
authors.lastname: Stern
authors.forename: M L
authors.initials: ML
authors.lastname: Tuck
mesh_terms: D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001092:Arachidonate 12-Lipoxygenase / Q000378:metabolism*; D002118:Calcium / Q000502:physiology*; D004594:Electrophysiology; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology; D044950:Flavanones; D005419:Flavonoids / Q000494:pharmacology; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000378:metabolism / Q000502:physiology*; D051381:Rats; D011919:Rats, Inbred Strains; D015398:Signal Transduction
chemical_list: D005231:Fatty Acids, Unsaturated; D044950:Flavanones; D005419:Flavonoids; D000804:Angiotensin II; C026603:5,8,11-eicosatriynoic acid; C006680:baicalein; D001092:Arachidonate 12-Lipoxygenase; D002118:Calcium